Novanta Inc. (NOVT) investor relations documents from the company's IR site: 2 presentations; latest deck 2025-09-09. Read in-app with summaries. First-party data.
Baird 2025 Global Healthcare Conference Presentation — Novanta's confidential investor document outlines its strategy as a trusted technology partner for Medical & Industrial OEMs, highlighting its ~$6B TAM and focus on growth
| Published | Type | Document |
|---|---|---|
| 2026-04-24 | Proxy statement | Novanta 2026 Proxy Statement of 2025 Annual Report & Proxy, PDF file, (opens in new window) |
| 2026-04-24 | Annual report | Novanta 2025 Annual Report of 2025 Annual Report & Proxy, PDF file, (opens in new window) |
| 2025-09-09 | Presentation | Baird 2025 Global Healthcare Conference Presentation |
| 2025-04-22 | Annual report | Novanta 2024 Annual Report of 2024 Annual Report & Proxy, PDF file, (opens in new window) |
| 2023-12-27 | Presentation | CJS 24th Annual New Ideas for the New Year Conference Presentation |
| 2021-04-26 | Proxy statement | Novanta 2021 Proxy Supplement No.2 of 2020 Annual Report & Proxy, PDF file, (opens in new window) |
| Financial supplement | Adjusted Diluted EPS - PDF (opens in new window) | |
| Financial supplement | Adjusted Gross Profit & Adjusted Gross Profit Margin (Non-GAAP) - PDF (opens in new window) | |
| Financial supplement | REVENUE, BOOKINGS, AND BOOK-TO-BILL BY SEGMENT - PDF (opens in new window) |
NOVT overview · NOVT earnings · NOVT financials · NOVT KPIs · NOVT ownership · NOVT peers · NOVT filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.